Vivimed Labs repurchases $12.5 million convertible bonds due 2012

By Devika Patel

Knoxville, Tenn., Sept. 2 - Vivimed Labs Ltd. informed the Bombay Stock Exchange that it bought back $12.5 million of its $15 million in foreign-currency convertible bonds due 2012.

The remaining $2.5 million in bonds were converted into equity shares by the investors.

Vivimed Labs produces oral care, sun care and hair care products and is based in Hyderabad, India.

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.